Condition: Locally Advanced Rectal Cancer · Sponsor: Jinhua Central Hospital
phase II clinical trial to evaluate node-sparing short-course radiation combined with total neoadjuvant CAPOX and Sintilimab for MSS locally advanced rectal cancers.
This description comes directly from the study's public registry record.
jinlin du, master · 86 13957998111 · djl9090@163.com
cheng cai, master · 86 18395995912 · ColoSurg_cc@zju.edu.cn
Always discuss trial participation with your own doctor first.
| Zhejiang University Affiliated Jinhua Hospital | Jinhua, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06204094